Haemacure financing receives shareholder consent - Series B Warrants a... ( and changes to the competitive environm...)

Haemacure financing receives shareholder consent - Series B Warrants are amended

Date:5/14/2008

, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Haemacure disclaims any intention or obligation to update these statements.

SCHEDULE

Number of Percentage

Number of Number of Common of Common

Shares Series B Shares - Shares -

Name of Insider Held / Warrants Post Post

and Position Controlled Held Exercise Exercise

--------------- ---------- --------- --------- ----------

Firebird Global Master

Fund II, Ltd

Holder of more than

10% of outstanding

shares 15,000,000 7,500,000 30,000,000 10.4

Firebird Global Master

Fund, Ltd

Holder of more than 10%

of outstanding shares 10,000,000 5,000,000 20,000,000 6.9

Galli, Joseph

Officer and Director 2,216,300 650,000 3,516,300 1.2

Paquin, Marc

Officer and Director 1,947,000 250,000 2,447,000 0.8

Johnson, Wayne

Director 415,770 175,000 765,770 0.3

Alary, Pierre

Director 314,000 125,000 564,000 0.2

Baehr, Paul

Director 265,000 125,000 515,000 0.2

Lemieux, Gilles

Officer 279,350 25,000 329,350 0.1

Pare, Lyne

Officer 50,000 25,000 100,000 0.03

---------- ------------------------------------

Total 30,620,920 13,875,000 5
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
2. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
3. Haemacure Reports on its annual general and special meeting of shareholders
4. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
5. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
6. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
7. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
8. Haemacure Reports Third Quarter 2007 Results
9. InfoLogix Completes $25 Million Senior Debt Financing
10. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
11. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures

Post Your Comments:

Haemacure financing receives shareholder consent - Series B Warrants a...( and changes to the competitive environm...),Health